TrialInternational journal of hematology2010

Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group.

Yasuyoshi Morita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.